Peripheral Nerve Regeneration in a Novel Rat Model of Dysphagia.
Animals
Cell Culture Techniques
Culture Media, Conditioned
/ pharmacology
Deglutition Disorders
/ diagnosis
Disease Models, Animal
Gagging
Humans
Male
Nerve Regeneration
Peripheral Nerves
/ physiology
Phenotype
Rats
Regenerative Medicine
Stem Cells
/ metabolism
Symptom Assessment
Tooth, Deciduous
/ cytology
Conditioned medium (CM)
Dysphagia
Stem cells from human exfoliated deciduous teeth (SHED)
Superior laryngeal nerve (SLN)
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
1
6
2020
pubmed:
1
6
2020
medline:
18
3
2021
Statut:
ppublish
Résumé
The superior laryngeal nerve (SLN) is known to play an essential role in the laryngeal reflex and swallowing. Damage to the SLN causes difficulty swallowing, that is, dysphagia. We successfully developed a novel rat model of dysphagia by SLN injury, in which we could evaluate the neuroregenerative capacity of stem cell from human exfoliated deciduous teeth (SHED). The dysphagic rats exhibit weight loss and altered drinking patterns. Furthermore, SLN injury induces a delayed onset of the swallowing reflex and accumulation of laryngeal debris in the pharynx. This rat model was used to evaluate the systemic application of SHED-conditioned medium (SHED-CM) as a therapeutic candidate for dysphagia. We found that SHED-CM promoted functional recovery and significant axonal regeneration in SLNs through the polarization shift of macrophages from activated inflammatory macrophages (M1) to anti-inflammatory macrophages (M2) and angiogenesis. This chapter describes the establishment of SLN-injury induced dysphagia rat model and the preparation and application of SHED-CM.
Identifiants
pubmed: 32474871
doi: 10.1007/978-1-0716-0655-1_9
doi:
Substances chimiques
Culture Media, Conditioned
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM